Trial document
This trial has been registered retrospectively.
DRKS00010768
Trial Description
Title
Function of the left atrium after interventional closure of the left atrial appendage
Trial Acronym
LAA Closure - Hemodynamic Study
URL of the Trial
[---]*
Brief Summary in Lay Language
The interventional closure of the left atrial appendage, which is thought to be a potential source of blood clots in patients with atrial fibrillation, has become a new alternative therapeutic strategy to oral anticoagulation. One of the regulating mechanisms to volume overload is the neurohumoral response. A strech of the atrial wall causes a secretion of natriuretic peptides, which are stored in large quantities in the walls of the left atrial appendage. The exclusion of the left atrial appendage from the systemic circulation may result in a reduced systemic response to hemodynamic changes. The aim of this study is to investigate potential changes of the neuroendocrine response after interventional atrial appendage closure.
Brief Summary in Scientific Language
Patients with atrial fibrillation have an increased risk of stroke compared to general population. Intracardiac thrombi in patients with non-valvular atrial fibrillation has been found in approximately 90% of cases in the left atrial appendage. The percutaneous, interventional closure of the left atrial appendage has become a new, alternative treatment strategy for patients with atrial fibrillation and a contraindication to oral anticoagulation.
In the PROTECT AF study patients with non-valvular atrial fibrillation were randomized at a ratio of 2 to 1 either the interventional LAA closure with the Watchman occluder or the conventional anticoagulation with Warfarin.
The study's primary endpoint was freedom of stroke, cardiovascular death and systemic embolism. Safety endpoints were significant bleeding, pericardial effusion and occluder dislocation.
The most recently published follow up data from this study showed a significantly reduced all-cause mortality and cardiovascular mortality in the interventional group with equalized safety endpoints.
The volume of the left atrial appendage makes up to one third of the left atrium. The contribution of the atrial appendage contraction to the cardiac pump function is low or negligible. The importance of the left atrial appendage is thought to be the perception of the left ventricular end diastolic pressure and the systemic response to deviations from the normal conditions. This is done via the secretion of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), which are synthetized and stored in large quantities in the walls of the left atrial appendage.
The secretion of ANP and BNP depends on the haemodynamic state; changes of the volume load lead to strech of the walls of the left atrium and left atrial appendage. Tabata described that the increase of the plasma levels of ANP correlated with the strech of the wall of the left atrial appendage. The exclusion of the left atrial appendage from the systemic circulation after interventional atrial appendage closure could result in a reduced systemic response to hemodynamic changes. The aim of our study is to investigate potential changes in the neuroendocrine response and its clinical significance after interventional atrial appendage closure.
Do you plan to share individual participant data with other researchers?
[---]*
Description IPD sharing plan:
[---]*
Organizational Data
- DRKS00010768
- 2016/07/07
- [---]*
- yes
- Approved
- 10/15, Ethikkommission der Medizinischen Fakultät der Otto-von-Guericke-Universität Magdeburg
Secondary IDs
- [---]*
Health Condition or Problem studied
- I48.1 - [generalization I48: Atrial fibrillation and flutter]
Interventions/Observational Groups
- Patients with an indication for an interventional atrial appendage closure and successful procedure are involved in our study after giving their informed consent. Patients undergo an Evaluation including Determination of ANP/BNP and Routine laboratory Tests as well as thransthoracic and transesophageal echocardiography and 6 min Walk Test before the procedure, 45 days and 6 months thereafter.
Characteristics
- Non-interventional
- Other
- Single arm study
- Open (masking not used)
- [---]*
- Uncontrolled/Single arm
- Diagnostic
- Single (group)
- N/A
- No
Primary Outcome
Primary Outcome measure is the proof of a significant Change in the neurohumoral Response to hemodynamic overload after successful closure of the left atrial appendage
Secondary Outcome
Thrombogenesis and position of the atrial appendage closure device in the transesophageal echocardiography 45 days and 6 months after the Implantation prozedure.
Countries of Recruitment
- Germany
Locations of Recruitment
- University Medical Center
Recruitment
- Actual
- 2015/05/04
- 150
- Monocenter trial
- National
Inclusion Criteria
- Both, male and female
- 18 Years
- no maximum age
Additional Inclusion Criteria
Age over 18 years; both gender; all ethnic Groups; Weight: no Limitation; women: excluded pregnancy; procedure: successful interventional closure of the left atrial appendage.
Exclusion Criteria
Patients with known coronary heart disease or instable angina pectoris, severe valvular heart disease, severe diastolic dysfunction, severe pulmonary hypertension, anaemia, acute infection with fever and increase of C reactive protein and/or leukocytosis, isolated leukocytosis, increased C reactive protein, severe renal or liver insufficiency, neoplasia, pregnancy
Addresses
-
start of 1:1-Block address primary-sponsor
- Universitätsklinikum Magdeburg
- Leipziger Str. 44
- 39120 Magdeburg
- Germany
end of 1:1-Block address primary-sponsorstart of 1:1-Block address contact primary-sponsor- [---]*
- [---]*
- [---]*
- http://www.med.uni-magdeburg.de
end of 1:1-Block address contact primary-sponsor -
start of 1:1-Block address scientific-contact
- Universitätsklinikum MagdeburgKlinik für Kardiologie und Angiologie
- Mr. Dr. med. Blerim Luani
- Leipzigerstr. 44
- 39120 Magdeburg
- Germany
end of 1:1-Block address scientific-contactstart of 1:1-Block address contact scientific-contact- 0391 67 15 206
- 0391 67 15 211
- blerim.luani at med.ovgu.de
- http://www.kkar.ovgu.de/
end of 1:1-Block address contact scientific-contact -
start of 1:1-Block address public-contact
- Universitätsklinikum MagdeburgKlinik für Kardiologie und Angiologie
- Mr. Dr. med. Blerim Luani
- Leipzigerstr. 44
- 39120 Magdeburg
- Germany
end of 1:1-Block address public-contactstart of 1:1-Block address contact public-contact- 0391 67 15 206
- 0391 67 15 211
- blerim.luani at med.ovgu.de
- [---]*
end of 1:1-Block address contact public-contact
Sources of Monetary or Material Support
-
start of 1:1-Block address materialSupport
- Universitätsklinikum Magdeburg
- Leipzigerstr. 44
- 39120 Magdeburg
- Germany
end of 1:1-Block address materialSupportstart of 1:1-Block address contact materialSupport- [---]*
- [---]*
- [---]*
- [---]*
end of 1:1-Block address contact materialSupport
Status
- Recruiting ongoing
- [---]*
Trial Publications, Results and other Documents
- [---]*